TALENT AAA STENT GRAFT
Report
- Report Number
- 2953200-2012-00774
- Event Type
- Death
- Date Received
- April 13, 2012
- Report Date
- March 19, 2012
- Manufacturer
- MEDTRONIC CARDIOVASCULAR
- Product Code
- MIH
- PMA / PMN Number
- P070027
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NY, US
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4). EVALUATION RESULTS: INHERENT RISK OF PROCEDURE (DEATH, ENDOLEAK, RUPTURE), PATIENT'S CONDITION AFFECTED EFFECTIVENESS OF DEVICE (ANATOMY RELATED). EVALUATION CONCLUSION: DEVICE FAILURE/LACK OF EFFECTIVENESS RELATED TO PATIENT CONDITION (ANATOMY RELATED).
MEDTRONIC RECEIVED THE FOLLOWING INFORMATION OBTAINED FROM THE JOURNAL ARTICLE J VASC SURG 2012, WHICH IS SUMMARIZED AS FOLLOWS. WOMEN DERIVE LESS BENEFIT FROM ELECTIVE ENDOVASCULAR ANEURYSM REPAIR THAN MEN, MEHTA ET AL. THE MEDTRONIC STENTS USED IN THIS STUDY WERE ANEURX AND TALENT. ALL EVARS WERE PERFORMED BY SURGICAL EXPOSURE OF THE COMMON FEMORAL OR DISTAL EXTERNAL ILIAC ARTERIES. FOR WOMEN, ELECTIVE EVAR RESULTED IN SIGNIFICANTLY GREATER MORTALITY RATES THAN MEN (3.2% VS 0.96%, P=.005). THERE WAS A GREATER INCIDENCE OF INTRAOPERATIVE AORTIC NECK, OR ILIAC ARTERY RUPTURE (4.1% VS 1.2% P= 0.002) AND PALMAZ STENT PLACEMENT FOR TYPE 1 ENDOLEAKS (16.1% VS 8%, P=0.0009). PERIOPERATIVE COMPLICATIONS WERE ALSO MORE FREQUENT IN WOMEN: LEG ISCHEMIA (3.5% VS 0.6%, P=0.003) AND COLON ISCHEMIA REQUIRING COLECTOMY (0.9% VS 0.2%, P=0.009). THE CAUSES OF DEATH (N=11) WERE AORTIC NECK RUPTURE (N=2), ILIAC ARTERY RUPTURE (N=4), COLON ISCHEMIA (N=1), AND MULTISYSTEM ORGAN FAILURE (N=4). COLON ISCHEMIA, NATIVE ARTERIAL RUPTURE, AND TYPE 1 ENDOLEAKS ARE MORE FREQUENT. ONE THOUSAND SIX HUNDRED NINETY EIGHT EVAR PROCEDURES DONE FROM 2002-2009.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TALENT AAA STENT GRAFT | SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | MEDTRONIC CARDIOVASCULAR |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |